Cilon Pharma ApS
CVR 45161293 · Private limited company (ApS) · Active · Medium risk
Cilon Pharma ApS is a Private limited company (ApS), founded on , based in Farum. The company is registered in the industry engroshandel med medicinalvarer og sygeplejeartikler. Our model estimates a bankruptcy risk of 2.0% over the next 12 months, which is 1.4 times the average for Danish companies. 1 annual report has been published. The latest annual report (31 Dec 2025) shows equity of DKK 44k and a net result of DKK 4,374. CEO: Alyaa Hashim Jaber Bilal.
Bankruptcy risk for Cilon Pharma ApS
1.4 × the average (1.41%) · higher risk than 82% of active Danish companies
Increases the risk
Reduces the risk
The factors show how often companies with the same characteristic went bankrupt compared with the average (“lift”). The risk is a statistical estimate from a model trained on 141,000+ Danish bankruptcies (AUC 0.93) – not a credit rating. Read about the method.
Company details
- CVR number
- 45161293
- Status
- Active
- Company type
- Private limited company (ApS)
- Founded
- (2 years)
- Address
- Nygårdterrasserne 275A
3520 Farum - Municipality
- Furesø
- Industry
- Engroshandel med medicinalvarer og sygeplejeartikler (464610)
Bankruptcies in the industry: Engroshandel med andre maskiner og andet udstyr - Share capital
- DKK 40k
- Audit opted out
- Yes
Warning signs
| Annual reports filed late | 0 of 1 |
| Missing annual report | No |
| Negative equity | No |
| Equity ratio | 97.0% |
| Current ratio | 3,368% |
| Moves (last 2 years) | 0 |
| CEO changes in total | 0 |
| CEO's previous bankruptcies | 0 |
| Other companies at the address | 0 |
| Going-concern uncertainty | No |
Financials and key figures
| Financial year | 2025 |
|---|---|
| Gross profit | DKK 5,867 |
| Net profit | DKK 4,374 |
| Equity | DKK 44k |
| Total assets | DKK 46k |
| Cash | DKK 46k |
| Short-term debt | DKK 1,358 |
| Tax owed | DKK 1,358 |
| Avg. employees | 0 |
Latest annual report: Reporting class B · auditor's statement: No assurance.
Filed annual reports
| Reporting period | Published | Days after period end | |
|---|---|---|---|
| 15 Oct 2024 – 31 Dec 2025 | 172 |
The annual report must reach the Danish Business Authority no later than 5 months after the end of the financial year. We mark reports published more than 6 months after as “late”.
Management, owners and auditor
| Role | Name | From | To |
|---|---|---|---|
| CEO | Alyaa Hashim Jaber Bilal | Current | |
| Owner (33%) | Alyaa Hashim Jaber Bilal | Current | |
| Owner (33%) | Reem Mohanad Abdulrazzaq Al-Anssari | Current | |
| Owner (33%) | Marteena Amer Toma Zomaya | Current | |
| Founder | Alyaa Hashim Jaber Bilal | Current | |
| Founder | Reem Mohanad Abdulrazzaq Al-Anssari | Current | |
| Founder | Marteena Amer Toma Zomaya | Current |
Address history (0 moves)
| Nygårdterrasserne 275A, 3520 Farum |
Similar companies in Furesø
- NovuDent ApS Værløse
- Vikta ApS Værløse
- Egoo.Health ApS Værløse
- Canngros ApS Værløse
- AXICORP ApS Farum
- TABS'N CAPS ApS Værløse
- SCANOVEL ApS Farum
- ALCORLAB A/S Værløse
Questions and answers about Cilon Pharma ApS
Has Cilon Pharma ApS gone bankrupt?
No, Cilon Pharma ApS is not registered as bankrupt in the CVR register. Its status is: active.
What is the bankruptcy risk of Cilon Pharma ApS?
Our model estimates a bankruptcy risk of 2.0% over the next 12 months (medium risk), which is 1.4 times the average for Danish companies.
Who is the CEO of Cilon Pharma ApS?
Alyaa Hashim Jaber Bilal is the CEO of Cilon Pharma ApS.
When was Cilon Pharma ApS founded?
Cilon Pharma ApS was founded on 15 October 2024.
What is the equity of Cilon Pharma ApS?
Equity was DKK 44k according to the annual report for the period ending 31 December 2025.
Source: the CVR register and annual reports published by the Danish Business Authority. The information is updated continuously.